‘Vaccinating 130 cr people with injectable Covaxin a challenge’

Even as India’s first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query on how to vaccinate 1.3 billion (130 crore) people with two injectable doses. Terming the exercise a challenge it also said that work was on single-dose nasal drop vaccine. Continue Reading

Covaxin: Bharat Biotech gets nod for phase 3 trials

Covaxin, the Coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials. Continue Reading

ICMR’s advisory for Feluda paper strip test

The Indian Council of Medical Research has issued an advisory for the use of indigenously developed Feluda paper strip test, which is based on CRISPR-Cas9 technology for diagnosis of SARS-CoV-2, by the laboratories. Continue Reading

Covid-19 reinfection likely if antibodies reduce within 5 months of recovery: ICMR

Indian Council of Medical Research (ICMR)’s Director-General Dr Balram Bhargava has said coronavirus re-infection is likely if the antibodies reduce in patients within five months of recovery. Continue Reading

ICMR to study possibilities of Covid-19 reinfection

Union Health Minister Dr Harsh Vardhan has said the ICMR is set to commission a study on the possibilities of reinfection, though reports of reinfections coming from several States were ‘misclassified’. Continue Reading

All you should know about Cat Que Virus

Even as the world is still grappling with the COVID-19 pandemic, the Indian Council of Medical Research (ICMR) scientists have found another virus, the ‘Cat Que Virus,’ reported mainly in China. Continue Reading

Another virus from China has potential to cause disease in India: ICMR

At a time when India’s fight with Covid-19 itself is still continuing, scientists at the Indian Council of Medical Research (ICMR) have discovered another virus called ‘Cat Que Virus’ (CQV) which has the potential to cause disease in the country. Continue Reading

Covid-19 vaccine likely to have 50-100% efficacy, says ICMR

Indian Council of Medical Research (ICMR) has said the vaccine against coronavirus disease (Covid-19) is likely to be anywhere between 50 to 100% effective. Continue Reading

No significant mutation of coronavirus in India: Health Minister

No significant or drastic mutation in strains of SARS-CoV-2 has been found in India till now, Union Minister for Health and Family Welfare Harsh Vardhan has said. Continue Reading